Keyan Salari, MD @KeyanSalari of Massachusetts General Hospital @MGHUrology discusses 5-alpha reductase inhibitors and risk of overall and fatal bladder cancer.
Advertisement Single Below Content
Advertisement Single Below Content
Advertisement Single Below Content